Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis.

Lubberts E, Joosten LA, Oppers B, van den Bersselaar L, Coenen-de Roo CJ, Kolls JK, Schwarzenberger P, van de Loo FA, van den Berg WB.

J Immunol. 2001 Jul 15;167(2):1004-13.

2.

[Proinflammatory cytokine interleukin-17 and its role in pathogenesis of rheumatoid arthritis].

Leonaviciene L, Bradūnaite R, Astrauskas V.

Medicina (Kaunas). 2004;40(5):419-22. Review. Lithuanian.

3.

Joint inflammation and cartilage destruction may occur uncoupled.

van den Berg WB.

Springer Semin Immunopathol. 1998;20(1-2):149-64. Review.

PMID:
9836374
4.

The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis.

Li X, Yuan FL, Lu WG, Zhao YQ, Li CW, Li JP, Xu RS.

Biochem Biophys Res Commun. 2010 Jun 25;397(2):131-5. doi: 10.1016/j.bbrc.2010.05.111. Epub 2010 Jun 1. Review.

PMID:
20513356
5.

The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.

Lubberts E, Koenders MI, van den Berg WB.

Arthritis Res Ther. 2005;7(1):29-37. Epub 2004 Nov 30. Review.

6.

Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction.

van den Berg WB, Joosten LA, Kollias G, van De Loo FA.

Ann Rheum Dis. 1999 Nov;58 Suppl 1:I40-8. Review.

7.

C1q in autoimmune diseases: rheumatoid arthritis.

Maeurer MJ, Trinder PK, Störkel S, Loos M.

Behring Inst Mitt. 1993 Dec;(93):262-78. Review.

PMID:
8172576
8.
9.

In vivo evidence for a key role of IL-1 in cartilage destruction in experimental arthritis.

van den Berg WB, van de Loo FA, Otterness I, Arntz O, Joosten LA.

Agents Actions Suppl. 1991;32:159-63. Review.

PMID:
2069084
10.

Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis.

Ferraccioli G, Bracci-Laudiero L, Alivernini S, Gremese E, Tolusso B, De Benedetti F.

Mol Med. 2010 Nov-Dec;16(11-12):552-7. doi: 10.2119/molmed.2010.00067. Epub 2010 Aug 2. Review.

11.
12.

Animal models of infectious arthritis.

Mahowald ML.

Clin Rheum Dis. 1986 Aug;12(2):403-21. Review.

PMID:
3542351
13.

Cellular basis and oncogene expression of rheumatoid joint destruction.

Gay S, Gay RE.

Rheumatol Int. 1989;9(3-5):105-13. Review.

PMID:
2692124
14.

Vasculature of the normal and arthritic synovial joint.

Haywood L, Walsh DA.

Histol Histopathol. 2001 Jan;16(1):277-84. Review.

PMID:
11193203
15.

Immunotherapy in collagen-induced arthritis: past, present, and future.

Wooley PH.

Am J Med Sci. 2004 Apr;327(4):217-26. Review.

PMID:
15084918
16.

Synovial lymphocytes and the aetiology of synovitis.

Gaston H.

Ann Rheum Dis. 1993 Mar;52 Suppl 1:S17-21. Review. No abstract available.

17.

[Gene therapy in rheumatoid polyarthritis: perspectives].

Bessis N, Boissier MC.

Presse Med. 1998 Mar 28;27(12):580-2. Review. French.

PMID:
9767955
18.

Experimental models of arthritis and related connective tissue diseases and some naturally occurring counterparts in animals.

[No authors listed]

Arthritis Rheum. 1970 Sep-Oct;13(5):621-33. Review. No abstract available.

PMID:
4921541
19.

Animal models of rheumatoid arthritis.

Sokoloff L.

Int Rev Exp Pathol. 1984;26:107-45. Review. No abstract available.

PMID:
6400511
20.

What we learn from arthritis models to benefit arthritis patients.

van den Berg WB.

Baillieres Best Pract Res Clin Rheumatol. 2000 Dec;14(4):599-616. Review.

PMID:
11092791

Supplemental Content

Support Center